Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gout nephropathy--ghost or reality?].

U Huynh-Do1

  • 1Klinik und Poliklinik für Nephrologie und Hypertonie, Universitätsspital Bern, Inselspital, Bern. uyen.huynh-do@insel.ch

Therapeutische Umschau. Revue Therapeutique
|October 21, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

No association of complement mannose-binding lectin deficiency with cardiovascular disease in patients with Systemic Lupus Erythematosus.

Scientific reports·2020
Same author

Externalized Percutaneous Stent Versus Internal Double J Stent: Short- and Long-term Complications After Kidney Transplantation.

Transplantation proceedings·2018
Same author

[Assessment of kidney function : Creatinine is not the whole story].

Der Internist·2018
Same author

Impact of cardio-renal syndrome on adverse outcomes in patients with Fabry disease in a long-term follow-up.

International journal of cardiology·2017
Same author

BK Polyomavirus-Specific 9mer CD8 T Cell Responses Correlate With Clearance of BK Viremia in Kidney Transplant Recipients: First Report From the Swiss Transplant Cohort Study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.

Cellular signalling·2013

Gout rarely causes kidney damage, but chronic lead intoxication can present as gout with kidney failure. EDTA chelation therapy can slow kidney disease progression in these cases.

Area of Science:

  • Nephrology
  • Toxicology
  • Rheumatology

Context:

  • Historically, end-stage renal disease was a primary concern for gout patients.
  • Recent studies indicate hyperuricemia and gout seldom cause kidney damage independently.
  • Chronic lead intoxication is now recognized as a significant factor in gout-related renal issues.

Purpose:

  • To investigate the link between gout, chronic renal failure, and lead intoxication.
  • To evaluate the efficacy of EDTA chelation therapy in managing lead-induced renal insufficiency.

Summary:

  • Gout in patients with chronic renal failure may indicate underlying chronic lead intoxication.
  • The EDTA lead mobilization test can identify this condition.
  • Chelation treatment with EDTA demonstrated potential in slowing renal insufficiency progression without apparent harm.

Related Experiment Videos

Impact:

  • Highlights the importance of suspecting occult lead intoxication in gout patients with unexplained renal insufficiency.
  • Suggests active screening for lead exposure in this patient group.
  • Provides evidence for EDTA chelation as a therapeutic option for lead-induced renal disease.